Fortrea has selected Emery Pharma due to its strong capabilities in analytical and bioanalytical testing in support of Fortrea’s global clinical programs. Emery Pharma’s expertise in this area ...

Fortrea has launched a new R&D arm for AI-driven clinical trial technologies that it claims will make ... AI is already widely used in drug development and is advancing into clinical trials, ...

Potential Positives. Fortrea's sponsorship of the SCRS Collaborate Forward working group highlights its commitment to reducing administrative burdens in clinical research, showcasing the company's ...

Fortrea in Global Health | Clinical Trials Using Co-Innovation to Boost Productivity and ROI. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind.

Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board DURHAM, N.C., June 11, 2025 (GLOBE ...

The suite is already being used by AZ to deliver clinical trials in 40 countries and, according to the company, can reduce the time and cost of developing new medicines, bring care closer to home ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & ...

At the end of 2024, Fortrea had nearly $118.5 million in cash and cash equivalents. Fortrea carries roughly $1.7 billion of goodwill, primarily related to Labcorp's acquisition of Covance in 2015.

Fortrea helps its customers by running trials across more than 20 therapeutic areas across every phase of the development process, from clinical pharmacology to phase 4 studies conducted post ...

Noting that both Medpace and Fortrea trade at valuations that cannot support their fundamentals, the analyst downgraded the duo to Hold from Buy, lowering their price targets to $345 from $415 and ...

Clinical trials are an essential part of medical breakthroughs that help patients, but getting them off the ground and running them is often fraught with challenges. Specifically, qualification ...

Corvex Management LP has taken a stake in Fortrea Holdings Inc., a clinical trials management company that was spun out of Labcorp Holdings Inc. Bloomberg. Published 23 Oct 2024, 04:05 AM IST.